Back

Medpace

Scholars4

Papers4

Citations1

Related Papers (2)

Publication Date

Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial

The Lancet Diabetes & Endocrinology

IF41.8

2025-12-18

PREAI

Frederick J Raal; Jean Bergeron; Daniel Gaudet; Robert S Rosenson; David R Sullivan; Traci Turner; Robert A Hegele; Christie M Ballantyne; Joshua W Knowles; Nicholas J Leeper; Ira J Goldberg; Rong Zhou; Ma'an Muhsin; Jennifer Hellawell; James Hamilton; Gerald F Watts

Save

An Open-Label, Multi-Center Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) and Propranolol with G-CSF for the Mobilization of Stem Cells in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

BLOOD

IF23.1

2024-11-05

PREAI

Caculitan, Nina; Kim, Gayeon; Woolfrey, Ann; Akard, Luke P.; Jeong, Ah-Reum; Khouri, Jack; Shah, Gunjan L.; Cardarelli, Pina M.

Save